News | Breast Imaging | January 29, 2020

University of Chicago Offers Mammosphere from Life Image to Support WISDOM Study Participants, Improve Research

Top academic medical center to leverage leading breast health data tool to improve breast screening protocols for groundbreaking study

Mammogram showing dense breast tissue

January 29, 2020 — Life Image announced that it will provide Mammosphere, a breast health data access tool, to the University of Chicago Medicine to support recruitment for a pioneering research effort.

This leading academic medical center, which performed more than 14,000 outpatient mammography exams in 2018, serves a unique and diverse patient base across the Chicagoland area. It is the first Midwest expansion partner site for the WISDOM Study, a large-scale clinical trial aimed at developing optimal guidelines for breast cancer screening.

Mammosphere, a HIPAA-compliant, digital tool that allows women to securely request, store, and share breast images and reports with providers, will allow University of Chicago Medicine to bolster the accessibility and availability of prior breast health records. It creates a longitudinal view of the individual patient’s breast history to track changes over time, providing the historical medical records that are integral to support the WISDOM Study.

Life Image is also providing UChicago Medicine with the ability to streamline access to picture archiving communication systems (PACS) and electronic health record (EHR) systems in order to modernize processes for sharing information with patients. As WISDOM participation in the Chicago area increases, UChicago Medicine will be able to more effectively manage a high volume of requests from participants to receive and share breast health records without delay at its locations and affiliate sites. 

The WISDOM Study aims to recruit 100,000 women in order to improve breast cancer screening guidelines. The study follows participants over time to determine whether a personalized, risk-based screening protocol can improve clinical outcomes when compared to the current, one-size-fits-all approach to screening.

“As a partner of the WISDOM Study, we are committed to supporting the research that will end the confusion for all women around screening guidelines based on patients’ unique risk factors,” said Deepa Sheth, M.D., assistant professor of radiology, UChicago Medicine. “In the era of precision medicine, we have the opportunity to find the correct breast health screening protocol for an individual based on their risk, and by engaging our diverse community we can be certain the data and results are ethnically universal and applicable to any and all women.”

Mammosphere was developed to support women throughout their entire breast health journey, including contributing to scientific research. By offering patients this digital tool, patients in the WISDOM Study will have additional tools to support their long-term commitment to the research.

“It is an honor to work with one of the country’s top academic medical centers to provide the digital platform that enables this groundbreaking study,” said Matthew Michela, CEO, Life Image. “Life Image, UChicago Medicine, and the WISDOM Study are committed to working in tandem to answer critical questions to improve women’s breast health and the patient experience.”

WISDOM is a five-year longitudinal study that compares two different approaches to breast cancer screening – personalized screening versus annual screening. The personalized screening approach will take multiple risk factors into consideration, including genetic markers, to determine the most effective screening frequency and modality for an individual. Over time, the WISDOM Study hopes to discover which risk factors are most important, allowing regulators and providers to improve our screening recommendations accordingly. To learn more about the WISDOM Study, or sign up:

Related Content

Rebrand reflects Volpara Health's mission to prevent advanced-stage breast cancer
News | Breast Imaging | October 19, 2020
October 19, 2020 — Volpara Solutions, a leader in AI-powered breast density assessment, announced that it has changed
More than 600,000 women die of advanced breast cancer annually. (1) There is a safe, universally obtainable method to reduce this terrible toll according to MammaCare Foundation scientist Mark Kane Goldstein, Ph.D.

Module 1

News | Women's Health | October 15, 2020
October 15, 2020 — More than 600,000 women die of advanced breast cancer annually. ...
Released in the lead up to #DenseBreastDay (30 September) and Breast Cancer Awareness Month (October), the animation explains how breast density can complicate mammogram screening and make it harder for medical professionals to detect breast cancer. This highly engaging animation shows a polar bear hiding in a snow globe as an analogy for cancer hiding in dense breast tissue. 

Image provided by Dilon

News | Breast Density | October 07, 2020
October 7, 2020 — A group of Australia’s leading breast can...
Microscopic photo of a professionally prepared slide demonstrating breast tissue with ductal carcinoma in situ (DCIS). Immuhistochemistry of estrogen receptor positive. Micrograph of breast cancer. Slide shows corresponding length of 1 mm.

Microscopic photo of a professionally prepared slide demonstrating breast tissue with ductal carcinoma in situ (DCIS). Immuhistochemistry of estrogen receptor positive. Micrograph of breast cancer. Slide shows corresponding length of 1 mm. Getty Images

News | Breast Imaging | October 05, 2020
October 5, 2020 — A major study of women with ductal carcinoma in situ (...
ASTRO urges radiation oncology benefits management company eviCore to reconsider a move that requires shorter treatment regimens without regard for physician judgement

Getty Images

News | Radiation Oncology | October 02, 2020
October 2, 2020 — Radiation oncologists expressed serious concerns about a new private insurance coverage policy that
Girls in Tech, a global non-profit bringing the world together through education and experiences, is teaming up with McKesson, a global leader in healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information solutions, for a global hackathon to design innovative solutions for those impacted by breast cancer.

Getty Images

News | Women's Health | October 02, 2020
October 2, 2020 — Girls in Tech, a global non-profit bringing